Chad Billingsley gets platelet-rich plasma injection in elbow

6 Comments

Amid worries that Chad Billingsley will miss the remainder of the season after leaving his August 24 start with an elbow injury the Dodgers right-hander got a platelet-rich plasma injection yesterday.

For now the team is calling Billingsley’s injury merely “inflammation,” but Ken Gurnick of MLB.com notes that “the PRP injection is generally used for tears in tendons and ligaments.”

Don Mattingly indicated to Gurnick that Billingsley will attempt to start a throwing program after receiving the injection and if it doesn’t go smoothly he’ll likely be shut down for the year.

Billingsley has had a very strong season, starting 25 games with a 3.55 ERA and 128/45 K/BB ratio in 150 innings, posting his best ERA since 2008 and his best K/BB ratio ever.

Report: Orioles interested in Alex Cobb

Getty Images
1 Comment

MLB Network’s Jon Morosi reports that the Orioles have interest in free agent right-hander Alex Cobb, who rejected his one-year, $17.4 million qualifying offer from the Rays earlier this week. Cobb was most recently linked to the Cubs, who reportedly reached out to his agent during the GM Meetings and garnered mutual interest from the righty, but nothing appears to be set in stone yet.

Cobb, 30, completed his sixth season with the Rays in 2017. He went 12-10 in 29 starts and turned in a respectable 3.66 ERA, 6.4 SO/9 and career-best 2.2 BB/9 in 179 1/3 innings. Despite losing a couple of weeks to turf toe, he remained healthy for most of the year and showed no signs of the elbow issues that robbed him of the majority of his 2015-2016 campaigns.

It’s still fairly early for any deals to come to fruition, but Morosi notes that the Orioles seem to be focused on bulking up their rotation during the first few months of the offseason. It’ll take more than a healthy Alex Cobb to right that ship, however: Orioles’ starters earned a collective 5.70 ERA and 5.5 fWAR in 2017, good for worst and fourth-worst marks in the league, respectively. Behind Kevin Gausman and Dylan Bundy (and perhaps Gabriel Ynoa/Miguel Castro), they still need three viable starters to compete in 2018. Whether or not they can afford to spring for a single starter with Cobb’s price tag (four years, $48 million, per MLB Trade Rumors) remains to be seen.